HCPCS Q5128
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg (CMS descriptor)
Drugs Drug code Work RVU per service none (2024 fee schedule; adds 0 work RVUs)
Trend
Medicare payment on the code
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2023–2024.
Billers
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2023–2024.
| observed | calculated | calculated | calculated | calculated | calculated | reported | |
|---|---|---|---|---|---|---|---|
| 2024 | 470 | $169,309,392 | +77% | 937,303 | 1,124 | 7,080 | 0.00 |
| 2023 | 373 | $95,848,193 | not in the 2022 file | 442,174 | 675 | 4,149 |
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2023–2024.
By state
| observed | calculated | calculated | calculated | calculated | calculated | |
|---|---|---|---|---|---|---|
| Pennsylvania | 25 | $34,959,030 | 194,042 | 7,182 | 17,493 | |
| California | 60 | $21,722,063 | 120,525 | 1,570 | 5,747 | |
| Tennessee | 35 | $19,938,674 | 110,431 | 2,496 | 7,963 | |
| Texas | 58 | $18,380,790 | 101,866 | 1,158 | 5,529 | |
| New York | 33 | $10,308,394 | 57,032 | 1,542 | 3,874 | |
| Florida | 48 | $10,099,790 | 55,319 | 903 | 2,543 | |
| Minnesota | 18 | $9,245,090 | 51,108 | 2,130 | 6,939 | |
| Arizona | 20 | $7,685,476 | 42,384 | 892 | 5,318 | |
| South Carolina | 16 | $5,823,547 | 31,975 | 1,593 | 5,319 | |
| New Jersey | 20 | $4,586,598 | 25,607 | 1,191 | 3,310 | |
| Maryland | 20 | $3,917,973 | 21,584 | 505 | 2,445 | |
| Washington | 12 | $1,823,425 | 9,780 | 785 | 1,463 | |
| Colorado | 12 | $1,240,446 | 6,697 | 458 | 1,049 |
Not listed: 26 states with fewer than 11 billers (small cells).
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Providers placed by practice address. Data year 2024.
Top metro areas
| observed | calculated | calculated | calculated | calculated | |
|---|---|---|---|---|---|
| Philadelphia-Camden-Wilmington, PA-NJ-DE-MD | 24 | $34,947,511 | 193,979 | 7,245 | |
| New York-Newark-Jersey City, NY-NJ | 40 | $12,992,281 | 72,008 | 1,594 | |
| Los Angeles-Long Beach-Anaheim, CA | 24 | $8,033,804 | 44,502 | 1,038 | |
| Minneapolis-St. Paul-Bloomington, MN-WI | 17 | $7,234,449 | 39,923 | 2,086 | |
| Nashville-Davidson--Murfreesboro--Franklin, TN | 13 | $5,172,578 | 29,117 | 1,962 | |
| Phoenix-Mesa-Chandler, AZ | 12 | $5,065,897 | 27,617 | 2,029 | |
| Sacramento-Roseville-Folsom, CA | 16 | $4,801,463 | 26,969 | 1,737 | |
| Austin-Round Rock-San Marcos, TX | 12 | $4,699,903 | 26,126 | 1,447 | |
| Miami-Fort Lauderdale-West Palm Beach, FL | 17 | $4,395,710 | 24,069 | 1,521 | |
| Washington-Arlington-Alexandria, DC-VA-MD-WV | 18 | $3,614,638 | 19,767 | 594 | |
| Houston-Pasadena-The Woodlands, TX | 17 | $2,386,941 | 13,126 | 592 |
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). The 11 areas with the most payment among those with at least 11 billers; non-metro parts of each state are one area. Data year 2024.
Specialties billing Q5128 nationally
Ophthalmology accounts for 100% of payment for Q5128 nationally in 2024, across 1 specialties on claims.
| observed | calculated | calculated | calculated | calculated | calculated | |
|---|---|---|---|---|---|---|
| Ophthalmology | 470 | 100% | $169,309,392 | 100% | 937,303 | 1,994 |
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Provider-level lines (fewer than 11 beneficiaries suppressed by CMS); specialty is the provider type on claims. Data year 2024.
Top billers of Q5128 nationally
Named top billers are a Pro figure, and Pro is not available to buy, so this list is not shown to any account. The counts and totals by state, metro area and specialty on this page are free.
Original Medicare Part B fee-for-service only; CMS suppresses provider lines with fewer than 11 beneficiaries. How these figures are computed · Limitations